Skip to main content

Starcoin Group Limited (0399.HK)

Hong Kong Stock Exchange Consumer Defensive Household & Personal ProductsView data quality →
30.0Poor

ValueMarkers Composite Index

Top 0%#44,628 of 44,707

DCF data not available

Piotroski
2/9
Weak
Beneish
-4.57
Low Risk
Altman
-3.01
Distress
DCF Value
-
N/A
ROIC
-2.3%
Low
P/E
-0.7
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Starcoin Group Limited (0399.HK) — VMCI valuation read

0399.HK screens at VMCI 30/100, a 20-point gap below the Consumer Defensive sector median (50). For a mid-cap Starcoin Group Limited share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

0399.HK has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 0399.HK trades at 22.0x earnings, 22% above the Consumer Defensive median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Consumer Defensive group. Quality: ROIC of 16.0% sits 6.0pp above the Consumer Defensive median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 2.0x is the rate-sensitivity line to watch, which sets the rate-cycle exposure for Starcoin Group Limited.

0399.HK fell 2.0% over the trailing 7 days, with a -22.4% read on a 30-day basis.

Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong.

CEO: Ming Wu20 employeesHKwww.starcoingroup.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 0399.HK’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.